论文信息 - Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial - 字舞流文

Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial

L. Porcu | M. Milione | F. de Braud | G. Randon | F. Corti | S. Pusceddu | V. Amoroso | N. Prinzi | J. Coppa | M. Di Bartolomeo | I. Pulice | F. Panzuto | T. Cascella | D. Giuffrida | R. Leporati | G. Scotto | Carlo Spreafico | M.P. Brizzi | Davide Campana | S. Oldani | B. L. Stocchetti